Skip to content

Clinical Observation on the Efficacy of Fuzheng San Acupoint Sticking Therapy for Chemotherapy-Induced Myelosuppression in Gynecological Cancer Patients with Qi and Blood Deficiency Pattern

Clinical Observation on the Efficacy of Fuzheng San Acupoint Sticking Therapy for Chemotherapy-Induced Myelosuppression in Gynecological Cancer Patients with Qi and Blood Deficiency Pattern

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001064
Enrollment
Unknown
Registered
2025-05-28
Start date
2025-01-28
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical cancer ovarian cancer endometrial cancer

Interventions

interventional group:Routine treatment, nursing care + Fuzheng San Acupoint Sticking Therapy
control group:Routine treatment, nursing care + Placebo Acupoint Sticking Therapy

Sponsors

The Peoples Hospital Affiliated to Fujian University of Traditional Chinese Medicine Fuzhou
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
30 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1 : In line with cervical cancer ovarian cancer endometrial cancer in any diagnostic criteria confirmed by histopathology FIGO stage I ~ III patients with TC regimen chemotherapy 2 : The treatment plan is surgery + chemotherapy including neoadjuvant chemotherapy postoperative chemotherapy etc. without limiting the surgical procedure. 3 : in line with the diagnosis of traditional Chinese medicine and syndrome differentiation belongs to qi and blood deficiency type 4 : In line with the diagnostic criteria of bone marrow suppression according to the WHO bone marrow suppression classification in grade I-II. 5 : aged between 30 to 75 years old and expected survival = 3 months. 6 : KPS score = 60 points 7 : Bone marrow liver and kidney function were normal before intervention. 8 : Can be clearly expressed volunteered to participate in this study and signed informed consent.

Exclusion criteria

Exclusion criteria: 1 : Patients with malignant tumors of other systems or organs 2 : Combined with basic blood diseases severe infection respiratory insufficiency acute and chronic heart failure gastrointestinal bleeding jaundice severe hypertension chronic kidney disease stage 2 ~ 5 acute cerebrovascular disease and other serious heart brain liver lung kidney and other serious organ damage. 3 : Synchronous use of radiotherapy and other therapies 4 : For the application material and contains the relevant Chinese medicine ingredients have a history of allergy 5 : Skin ulceration at the application site 6 : Patients with mental illness 7 : Pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
chinese medicine syndrome scores;

Secondary

MeasureTime frame
Bone marrow suppression;The use of blood cell drugs;cytometry;

Countries

China

Contacts

Public ContactJinhua Huang

The Peoples Hospital Affiliated to Fujian University of Traditional Chinese Medicine

59526784@qq.com13799919620

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026